Sai Parenteral's Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Revenue	1,631	1,538	967.96
Revenue Growth (YoY)	6.08%	58.85%	-
Cost of Revenue	938.51	949.42	578.43
Gross Profit	692.55	588.19	389.53
Selling, General & Admin	141.06	132.33	98.71
Other Operating Expenses	152.42	134.07	94.76
Operating Expenses	375.52	366.5	251.4
Operating Income	317.03	221.69	138.13
Interest Expense	-115.64	-107.86	-47.04
Interest & Investment Income	3.28	3.16	1.91
Currency Exchange Gain (Loss)	-5.22	0.91	-10.7
Other Non Operating Income (Expenses)	-2.92	7.64	-9.79
EBT Excluding Unusual Items	196.53	125.54	72.51
Pretax Income	199.09	125.54	72.51
Income Tax Expense	54.82	41.39	28.75
Earnings From Continuing Operations	144.27	84.15	43.76
Earnings From Discontinued Operations	0.27	-	-
Net Income	144.54	84.15	43.76
Net Income to Common	144.54	84.15	43.76
Net Income Growth	71.77%	92.30%	-
Shares Outstanding (Basic)	27	16	14
Shares Outstanding (Diluted)	27	16	14
Shares Change (YoY)	65.94%	12.55%	-
EPS (Basic)	5.43	5.25	3.07
EPS (Diluted)	5.43	5.25	3.07
EPS Growth	3.50%	70.86%	-
Free Cash Flow	326.49	-648.33	-285.4
Free Cash Flow Per Share	12.27	-40.42	-20.02
Gross Margin	42.46%	38.25%	40.24%
Operating Margin	19.44%	14.42%	14.27%
Profit Margin	8.86%	5.47%	4.52%
Free Cash Flow Margin	20.02%	-42.16%	-29.48%
EBITDA	399.07	315.87	196.06
EBITDA Margin	24.47%	20.54%	20.26%
D&A For EBITDA	82.04	94.18	57.93
EBIT	317.03	221.69	138.13
EBIT Margin	19.44%	14.42%	14.27%
Effective Tax Rate	27.53%	32.97%	39.65%
Revenue as Reported	1,637	1,552	970.28
Advertising Expenses	-	0.5	0.37

Source: S&P Global Market Intelligence. Standard template. Financial Sources.